Lucid Diagnostics closed public offering of common stock as subsidiary of PAVmed Inc. (Nasdaq: PAVM) on Sept. 11, 2025.On September 11, 2025, Lucid Diagnostics Inc. (Nasdaq: LUCD), a company specializing in cancer prevention medical diagnostics and a subsidiary of PAVmed Inc. (Nasdaq: PAVM), completed the underwritten transaction as per its announcement.
